We are live on
!
Find out more
VAS
Vestmark Advisory Solutions Portfolio holdings
AUM
$9.02B
1-Year Est. Return
20.58%
This Fund
S&P 500
This Quarter
Est. Return
+20.83%
1 Year Est. Return
+20.58%
3 Year Est. Return
+60.75%
5 Year Est. Return
+71.02%
10 Year Est. Return
–
AUM
$646M
AUM Growth
+$135M
(+26%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
6.21%
Top 10 Holdings %
Top 10 Hldgs %
14.53%
Holding
565
New
91
Increased
280
Reduced
160
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$3.63M |
| 2 |
RTX Corp
RTX
|
+$1.78M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.76M |
| 4 |
AbbVie
ABBV
|
+$1.58M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.37M |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.02M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$1.62M |
| 4 |
Pfizer
PFE
|
+$1.55M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$1.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.97% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 11.31% |
| 4 | Industrials | 8.9% |
| 5 | Communication Services | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Protolabs
PRLB
$1.86B
| $344K | 0.05% |
3,062
+378
| +14% | +$38.8K |
|
377
Boston Properties
BXP
$11B
| $340K | 0.05% |
3,767
+124
| +3% | +$11.3K |
|
378
Bio-Rad Laboratories Class A
BIO
$8.42B
| $339K | 0.05% |
751
-155
| -17% | -$68.4K |
|
379
iShares US Technology ETF
IYW
$23.7B
| $339K | 0.05% |
5,024
-656
| -12% | -$39.6K |
|
|
SGEN
380
DELISTED
Seagen Inc. Common Stock
SGEN
| $337K | 0.05% |
1,981
+106
| +6% | +$15.8K |
|
381
Marvell Technology
MRVL
$174B
| $333K | 0.05% |
9,494
-633
| -6% | -$18.5K |
|
382
Smith & Nephew
SNN
$12.9B
| $333K | 0.05% |
8,728
-480
| -5% | -$19K |
|
383
Coca-Cola Europacific Partners
CCEP
$46.5B
| $332K | 0.05% |
8,796
+432
| +5% | +$16.9K |
|
384
Chemed
CHE
$6.78B
| $332K | 0.05% |
736
+83
| +13% | +$37.1K |
|
385
Carlisle Companies
CSL
$13.6B
| $332K | 0.05% |
2,776
-145
| -5% | -$17.4K |
|
386
Keysight
KEYS
$54.5B
| $332K | 0.05% |
3,298
+5
| +0.2% | +$491 |
|
387
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
| $330K | 0.05% |
+11,219
| New | +$314K |
|
388
SBA Communications
SBAC
$18.4B
| $329K | 0.05% |
1,106
-135
| -11% | -$39.8K |
|
389
Canadian National Railway
CNI
$78.3B
| $328K | 0.05% |
3,701
+254
| +7% | +$21.1K |
|
390
Cognizant
CTSH
$21.5B
| $326K | 0.05% |
5,729
+475
| +9% | +$25.5K |
|
391
National Grid
NGG
$82.7B
| $325K | 0.05% |
6,050
-292
| -5% | -$14.8K |
|
392
Sysco
SYY
$39.7B
| $324K | 0.05% |
5,923
+723
| +14% | +$38K |
|
393
Marathon Petroleum
MPC
$90.3B
| $323K | 0.05% |
+8,634
| New | +$277K |
|
394
SEI Investments
SEIC
$11.9B
| $316K | 0.05% |
5,739
-230
| -4% | -$12K |
|
395
Affiliated Managers Group
AMG
$9.46B
| $314K | 0.05% |
4,211
-423
| -9% | -$28.6K |
|
396
Prudential
PUK
$36.5B
| $314K | 0.05% |
10,669
+187
| +2% | +$4.95K |
|
397
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
| $314K | 0.05% |
3,278
| – | – |
|
|
NUVA
398
DELISTED
NuVasive, Inc.
NUVA
| $312K | 0.05% |
5,611
+86
| +2% | +$4.97K |
|
399
Bio-Techne
TECH
$11.2B
| $311K | 0.05% |
4,712
-556
| -11% | -$33.3K |
|
400
State Street
STT
$50.9B
| $310K | 0.05% |
4,872
-396
| -8% | -$23.9K |
|
Similar funds
A
AI
AI
AI
HI
SFM
MIH
RWP
Vestmark Advisory Solutions's Q2 2020 Portfolio in Review
As of Q2 2020, Vestmark Advisory Solutions held 565 positions worth $646M, up 26% from $512M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Vestmark Advisory Solutions deployed $40.1M of net new capital in Q2 2020, opening 91 new positions and adding to 280 existing holdings. Its largest new stake was Bright Horizons: 7,870 shares worth $922K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $1.55M trimmed.
- Vestmark Advisory Solutions's largest Q2 2020 buy was Bright Horizons: 7,870 shares worth $922K.
- Vestmark Advisory Solutions added most to State Street Financial Select Sector SPDR ETF in Q2 2020, an estimated $3.63M increase.
- Vestmark Advisory Solutions's biggest Q2 2020 reduction was Pfizer, cutting an estimated $1.55M.
- Vestmark Advisory Solutions fully exited Allergan plc in Q2 2020, selling an estimated $2.37M.
- Vestmark Advisory Solutions's ten largest holdings make up 15% of its $646M portfolio in Q2 2020.
- Vestmark Advisory Solutions opened 91 new positions and closed 32 in Q2 2020.
- Vestmark Advisory Solutions's portfolio value rose 26% quarter-over-quarter to $646M.
Based on Vestmark Advisory Solutions's 13F filing for Q2 2020, filed 13 Aug 2020.